accessibility menu, dialog, popup

UserName
Viewing profile as user:

Alkyl Halides

Organic compounds in which a hydrogen atom or more has been replaced by a halogen atom in an alkane molecule (saturated hydrocarbon chain). Halogen atoms include bromine, chlorine, fluorine, and iodine. Compounds may be in closed ring configurations.
Alkyl bromides (1,493)
Alkyl chlorides (551)
Halomethanes (378)
Alkyl fluorides (232)
Alkyl iodides (149)
Cyclohexyl halides (141)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

special offers

  • (580)
  • (1)

brands

  • (3)
  • (2)
  • (3)
  • (1)
  • (86)
  • (501)
  • (19)
  • (1)
  • (1)
  • (2)
  • (22)
  • (12)
  • (1)
  • (22)
  • (32)
  • (340)
  • (3)
  • (18)
  • (431)
  • (2)
  • (15)
  • (7)
  • (1)
  • (5)
  • (1)
  • (1)
  • (5)
  • (9)
  • (1)
  • (54)
  • (208)
  • (18)
  • (2)
  • (429)
  • (652)

special interests

  • (2)
  • (2)
  • (1)
  • (545)

Quantity

  • (24)
  • (104)
  • (14)
  • (1)
  • (4)
  • (45)
  • (1)
Show all

Molecular Weight (g/mol)

  • (1)
  • (1)
  • (1)
  • (1)
  • (5)
  • (2)
  • (1)
Show all

Percent Purity

  • (2)
  • (1)
  • (2)
  • (1)
  • (1)
  • (9)
  • (3)
Show all

Boiling Point

  • (5)
  • (2)
  • (3)
  • (5)
  • (4)
  • (5)
  • (3)
Show all

Physical Form

  • (2)
  • (3)
  • (10)
  • (123)
  • (6)
  • (2)
  • (6)
Show all

Grade

  • (1)
  • (4)
  • (1)
  • (4)
  • (2)
  • (8)
  • (2)
Show all

Product Line

  • (7)

Search Within Results
Keyword Search:
1,441 – 1,455 of 2,242 results
1,441

Medchemexpress LLC Demethylzeylasteral | 107316-88-1 | 480.59 | 20 MG
SDP

Demethylzeylasteral | 107316-88-1 | 480.59 | 20 MG

ENCOMPASS_PREFERRED
1,442

Medchemexpress LLC N-(4-((4-isopropylpiperazin-1-yl)sulfonylphenyl)-5-pentafluorophenyl)nicotinamide | 1803003-65-7 | 99.9% | 513.54 | 5 MG
SDP

RN-1665 is an orally active TRPV4 antagonist that exhibits excellent selectivity for related TRP receptors such as TRPV1, TRPV3, and TRPM8. RN-1665 is a TRPV4 probe for focus screens, with IC50s of 0.26 μM and 0.39 μM for hTRPV4 and rTRPV4 from human and rat, respectively.

  • IC50 for human TRPV4 is 0.26 μM.
  • IC50 for rat TRPV4 is 0.39 μM.
  • Antagonist activity at human TRPV4 receptor expressed in HEK293 cells assessed as inhibition of EC80 of 4alpha-PDD-stimulated calcium flux after 10 minutes.
  • Antagonist activity at rat TRPV4 receptor expressed in HEK293 cells assessed as inhibition of EC80 of 4alpha-PDD-stimulated calcium flux after 10 minutes.
  • Pharmacokinetic analysis has been performed in Wistar rats.

ENCOMPASS_PREFERRED
1,443

eMolecules​ 593-71-5 | Chloroiodomethane | Combi-Blocks | MFCD00001078 | 176.380 | CH2ClI | 98.000 | ClCI | 500g | 228814127

Chloroiodomethane | Combi-Blocks | 593-71-5 | MFCD00001078 | 176.380 | CH2ClI | 98.000 | ClCI | 500g | 228814127

ENCOMPASS_PREFERRED
1,444

Medchemexpress LLC 1-Propanone, 3,3,3-trifluoro-2-methoxy-1-[(7R)-7-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undec-3-yl]-2-phenyl-, (2R)- | 2413020-56-9 | 99.9% | 476.53 | 25 MG
SDP

BAY-593 is an orally active GGTase-I inhibitor. It can block YAP1/TAZ signaling in animals and has antitumor activity.

  • Orally active GGTase-I inhibitor
  • Blocks YAP1/TAZ signaling in animals
  • Exhibits antitumor activity
  • Inhibits proliferation of HT-1080 and MDA-MB-231 cells with IC50 values of 0.038 and 0.564 μM, respectively
  • Shows dose-dependent antitumor activity in HT-1080 fibrosarcoma and MDA-MB-231 triple negative breast cancer xenotransplantation mouse models

ENCOMPASS_PREFERRED
1,445

eMolecules​ 1343722-88-2 | ChemScene | 4-Chloro-2-fluorobenzothioamide | 250mg | 572194186 | CS-0114061 | MFCD17290209 | 189.63 | C7H5ClFNS

ChemScene | Sodium tetrahydrofuran-3-sulfinate | 250mg | 801476584 | CS-0530358 | 1622013-59-5 | MFCD28124335 | 158.150 | C4H7NaO3S

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>

ENCOMPASS_PREFERRED
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
1,446

eMolecules​ 1017-88-5 | DIMETHYLDIPHENYLPHOSPHONIUM IODIDE | AstaTech | MFCD00031576 | 342.160 | C14H16IP | 95.000 | [I-].C[P+](C)(c1ccccc1)c1ccccc1 | 1g | 718059157

DIMETHYLDIPHENYLPHOSPHONIUM IODIDE | AstaTech | 1017-88-5 | MFCD00031576 | 342.160 | C14H16IP | 95.000 | [I-].C[P+](C)(c1ccccc1)c1ccccc1 | 1g | 718059157

ENCOMPASS_PREFERRED
1,447

Medchemexpress LLC CCL4 MOUSE 100UG
SDP

5000195684 CCL4 MOUSE 100UG

ENCOMPASS_PREFERRED
1,448

Medchemexpress LLC CCL4 RAT 2UG
SDP

5000196147 CCL4 RAT 2UG

ENCOMPASS_PREFERRED
1,449

Medchemexpress LLC CCL4 MOUSE 50UG
SDP

5000196347 CCL4 MOUSE 50UG

ENCOMPASS_PREFERRED
1,450

Medchemexpress LLC TMPYP TETRACHLORIDE 5MG
SDP

5000205143 TMPYP TETRACHLORIDE 5MG

ENCOMPASS_PREFERRED
1,451

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000744045 METHYLENE BLUE PURI 25G

ENCOMPASS_PREFERRED
1,452

Ambeed AMBEED

5000891259 GOLDI IODIDE 50MG

ENCOMPASS_PREFERRED
1,453

Apexbio Technology LLC 360A iodide 737763-37-0 10mg
SDP

360A iodide (CAS 737763-37-0) is a 2 6-pyridine-dicarboxamide derivative that acts as a selective ligand for G-quadruplex DNA structures By stabilizing telomeric G-quadruplexes 360A inhibits telomerase activity and induces alterations in cell cycle progression notably causing S-phase accumulation in ATM-proficient EBV-lymphocytes Its mechanism of action involves promoting sister telomere fusions via DNA-PKcs-dependent non-homologous end joining (NHEJ) as well as triggering NHEJ and homologous recombination (HR) pathways at telomeres which disrupt mitotic progression 360A has been shown to preferentially bind telomeric G-quadruplex DNA over duplex DNA and to delay growth in HT1080 tumor cells This compound is valuable for investigating telomere biology DNA damage response and G-quadruplex-mediated genomic stability

ENCOMPASS_PREFERRED
1,454

Medchemexpress LLC BAY-593 | 2413020-56-9 | 99.9% | 476.53 | 50 MG
SDP

BAY-593 is an orally active GGTase-I inhibitor that can block YAP1/TAZ signaling in animals and exhibits antitumor activity. It is for research use only.

  • Orally active GGTase-I inhibitor.
  • Blocks YAP1/TAZ signaling in animals.
  • Possesses antitumor activity.
  • Inhibits the proliferation of HT-1080 and MDA-MB-231 cells with IC50 values of 0.038 and 0.564 μM, respectively, in vitro.
  • Shows dose-dependent antitumor activity in HT-1080 fibrosarcoma and MDA-MB-231 triple-negative breast cancer xenotransplantation mouse models in vivo.

ENCOMPASS_PREFERRED
1,455

Medchemexpress LLC Vilagletistat | 1542132-88-6 | 99.8% | 528.60 | C26H36N6O6 | 10 MG
SDP

Vilagletistat (ZED-1227) is a small-molecule, orally active transglutaminase 2 (TG2) inhibitor supplied for research use. It is provided as a high-purity powder in multiple package sizes and includes storage and stability guidance for powder and solutions.

  • High purity: reported 99.82% typical; example batch 99.97%.
  • CAS number 1542132-88-6.
  • Molecular formula C26H36N6O6 and molecular weight 528.60 g·mol^-1.
  • Available package sizes from 1 mg to 100 mg; larger quantities available by quote.
  • Storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).

ENCOMPASS_PREFERRED